-The Economic Times India has some of the best quaternary and tertiary care in the world and is gradually acquiring a name for itself even in the field of 'medical tourism'. Secondary care is still a significant challenge, but even in several smaller towns and district headquarters, there is a growing supply of maternity homes and multi-speciality secondary care facilities. At all of these levels of care, given the large disease burden...

-The Indian Express At a time when the government is struggling to get past objections from its coalition partners to attract investment in certain sectors such as retail, aviation and pensions fund management, a grim internecine ministerial battle has applied the brakes on foreign direct investment flow into one of the more attractive and lucrative sectors — pharmaceuticals. Clearances for over Rs 1,000 crore FDI in this sector, the second largest in...

-The Times of India Some good news for consumers might be at hand. You would soon be able to find the most affordable alternative to the medicine prescribed by your doctor through an SMS-based service. The service, expected to be launched by the government in August, will be available throughout the country. Here is how it works: Once the person sends a text message of the prescribed brand of drug to a...

-The Indian Express Government must bring the assisted reproductive technologies bill to Parliament. More stringent regulation could have saved lives Sushma Pandey, just 17 years old, reportedly died due to procedures related to egg harvesting conducted on her by a fertility clinic in Mumbai. Two years after her death, the Bombay high court did well to criticise the police for not prosecuting the hospital for its flagrant violation of the age requirement...

-The Economic Times It's not just the drug regulator, where a parliamentary panel has alleged corruption, failing in its job. Drug regulation across entities that dot this broad landscape is in poor health and ineffective. In May, when a Parliamentary panel, during a routine examination of healthcare regulatory bodies, alleged corruption in the approval of new drugs, it was merely pointing out one symptom. Such symptoms pervade the entire drug regulation landscape,...